Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Amortizatization of Intangibles: 2016-2024

Historic Amortizatization of Intangibles for Viridian Therapeutics, Inc.\DE (VRDN) over the last 9 years, with Dec 2024 value amounting to $15.7 million.

  • Viridian Therapeutics, Inc.\DE's Amortizatization of Intangibles fell 66.45% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 million, marking a year-over-year decrease of 47.07%. This contributed to the annual value of $15.7 million for FY2024, which is 36.25% up from last year.
  • According to the latest figures from FY2024, Viridian Therapeutics, Inc.\DE's Amortizatization of Intangibles is $15.7 million, which was up 36.25% from $11.5 million recorded in FY2023.
  • Viridian Therapeutics, Inc.\DE's 5-year Amortizatization of Intangibles high stood at $15.7 million for FY2024, and its period low was -$965,000 during FY2021.
  • Its 3-year average for Amortizatization of Intangibles is $9.1 million, with a median of $11.5 million in 2023.
  • In the last 5 years, Viridian Therapeutics, Inc.\DE's Amortizatization of Intangibles slumped by 466.92% in 2021 and then soared by 5,371.43% in 2023.
  • Yearly analysis of 5 years shows Viridian Therapeutics, Inc.\DE's Amortizatization of Intangibles stood at $263,000 in 2020, then plummeted by 466.92% to -$965,000 in 2021, then spiked by 121.76% to $210,000 in 2022, then soared by 5,371.43% to $11.5 million in 2023, then skyrocketed by 36.25% to $15.7 million in 2024.